ResMed | RMD - 债务

金融业

USD

USD 8.97B

现金及等价物

USD 1.47B

USD 612.93M

USD 4.32B

USD 1.4B

USD 843.17M

股息收益率

0.28

USD 454.34M

USD 559.78M

10.6K

EPS每股收益

USD 2.95

股本和储备

USD 6.59B

USD 861.22M

债务利息支出

USD 8.79M

USD 59K

USD 399.42M

USD 32.61B

USD 383.43M

USD 1.01B

USD 454.34M

普通股股本

USD 145.06M

18.29

USD 502.31M

USD 1.46B

销售和管理费用

USD 290.66M

USD 945.81M

贸易债权人

USD 308.92M

应收帐款人

USD 1.04B

	债务	更改		日
Ansell	USD 805.6M		51.6M	2025-06
Artivion	USD 317.78M		619K	2024-12
AtriCure	USD 71.78M		1.6M	2026-03
Baxter International	USD 9.69B		93M	2026-03
Cochlear	AUD 235.7M		10.9M	2025-06
Cooper Companies	USD 2.5B		5.6M	2025-12
CSL	USD 11.96B		219M	2024-12
Dexcom	USD 1.24B		900K	2026-03
Edwards Lifesciences	USD 600M		105.4M	2026-03
Globus Medical	USD 115.22M		3.43M	2026-03
Haemonetics	USD 1.22B		153K	2026-03
Idexx Laboratories	USD 1.1B		9.37M	2026-06
Inogen	USD 0		0	2022-06
Insulet	USD 948.4M		300K	2026-06
Integra LifeSciences	USD 2.04B		6.27M	2026-03
Intuitive Surgical	USD 0		0	2025-03
Medtronic	USD 28.07B		1.03B	2025-12
Philips	EUR 7.47B		632M	2026-06
Ramsay Health Care	AUD 12.12B		864.4M	2025-06
ResMed	USD 843.17M		4.55M	2026-03
Sigma Healthcare	AUD 137.64M		1.01M	2024-07
Sonic Healthcare	AUD 4.8B		282.9M	2024-12
Steris	USD 2.09B		33.5M	2026-03
Teleflex	USD 2.69B		39.95M	2026-03
Thermo Fisher Scientific	USD 43.16B		3.78B	2026-03